Navigation Links
Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
Date:7/31/2008

JERUSALEM, July 31 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that it will hold a conference call on August 6, 2008 at 10:30 AM EDT to present the results of its Phase 2A clinical trials of its flagship product, ORMD 0801, an oral insulin capsule.

Oramed's Phase 2A trial is focused on assessing the safety and efficacy of ORMD 0801. This study is a continuation of the successfully completed Phase 1 studies in Israel.
Interested parties should dial:

In the United States: +1-888-668-9141

All other locations: +972-3-918-0691

About Oramed Pharmaceuticals Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
2. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
3. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
5. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
6. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
7. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
8. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
9. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
10. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
11. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire/--AFOXThanksgivingDaytelevisionspecialcalled"...iewersthattheholidaysareatimetobegratefulformanyde...ofightthatbattleeachdayassurvivors,caregivers,anda...eturntotheiceofcancersurvivorsScottHamiltonandDoro...avidFosterwhowillperform"HopeisAlwaysHere,"asongwr...
(Date:11/24/2009)...PRNewswire-FirstCall/--BioSpecificsTechnologiesCor...ingfirstinclasscollagenase-basedproducts,todayanno...entattheupcomingPiperJaffray21stAnnualHealthCareCo...wYorkPalaceHotelinNewYork,NY. ,, Alivewebcastof..."intheInvestorRelationssectionoftheCompany,swebsit...
(Date:11/23/2009)...wire/--TwooftheChicagoarea,sleadingBoardCertifiedD...sbreastimaging,couplingthelatesttechnologyindigita...htheabilitytohavethefullrangeofdigitalimagingcompl...eavestheoffice.Drs.AhmedFaragandJoanWerberaredeliv...t6-9monthwaitforanappointmentcommonlyfoundinChicag...
Breaking Medicine Technology:FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3Axium Healthcare Pharmacy Inc Has Been Chosen as One of Central Floridas Golden 100 Companies for the Fifth Year in a Row 56618 1Axium Healthcare Pharmacy Inc Has Been Chosen as One of Central Floridas Golden 100 Companies for the Fifth Year in a Row 56618 2Red Cross Sees Increase in Youth Volunteers During United We Serve Program 56615 1Red Cross Sees Increase in Youth Volunteers During United We Serve Program 56615 2Red Cross Sees Increase in Youth Volunteers During United We Serve Program 56615 3U of I scientist 3A Public policy should promote family mealtimes 9845 1U of I scientist 3A Public policy should promote family mealtimes 9845 2U of I scientist 3A Public policy should promote family mealtimes 9845 3
...Data Presented on Valopicitabine Combined,with an ...in, April 12, 2007 /PRNewswire-FirstCall/ --,Ideni...om two phase,IIb studies of the novel combination ... alfa-2a (Pegasys(R)) in both treatment-naive,and ...genotype-1,strain of the hepatitis C virus (HCV). ...
...alif., April 11, 2007 (PRIME NEWSWIRE) --,Hana Bio...y focused,on advancing cancer care, will present p...Injection at the American Association,for Cancer R...Los,Angeles, California. , Abstract No. 2210: "Com... non-small cell lung cancer (NSCLC) athymic nude,m...
Other Medicine Technology:Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
(Date:11/25/2009)...e procedures that provide patients profound relief... or sinus infection, are being developed and used .... Techniques such as balloon sinuplasty clean blo...e any bone or tissue like traditional sinus surge...ating sinus symptoms were featured in a recent art...
(Date:11/25/2009)...California,s designated Premier Partner for Anthem...the November 15 - December 31 Annual Enrollment Pe...ero-cost PPO Medicare Advantage plan. Freedom Blue...rough BenefitPackages.com to eligible California s...PRWEB) November 25, 2009 -- The state of the econo...
(Date:11/25/2009)...mHealer,s GlobalIntentionHealsProjectprovedthatsen...atadistance.Over10,000participantssenthealinginten...uantitative-EEG.Thedatawasanalyzedbyworldexpertsin...Adaminitiatedtheworld,slargestintentionalhealingex...aspecificvisualizationtobeusedbyallparticipants,wh...
(Date:11/24/2009)...tion oncologists use advanced imaging techniques s...netic resonance imaging (MRI), and 4-dimensional c...to locate the tumor and other areas at risk for ha...ber issue of the Journal of the American College ...fining the target, the radiation oncologist draws ...
(Date:11/24/2009)...significantly higher risk of strokes and cardiovas...he British Medical Journal . , The research was...ion,s Collaborating Centre for Nutrition, based at... in Coventry, UK, and the European Society of Hype...t the Department of Clinical and Experimental Medi...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:BenefitPackages.com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 2Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:High salt intake linked to strokes and cardiovascular disease 2
... care have improved the survival of infants who ar...w study shows these babies are at risk for school ... now document the prevalence of neurological, beha...dren are likely to have a lower IQ and lower acade...
...high air pollution levels may make people more sus...rch, air pollution levels have been connected to d...heart disease. But research on air pollution and s...pital admissions. Researchers collected data ...
... and cars? Why doesn't he notice how much housewor...p on the remote control? And the most bewildering ...he answers, says social philosopher Michael Gurian...nology to prove it. "What Could He Be Thinking?...
...rating insoles can jumpstart the nervous system in...insoles to help people maintain better balance. Th...oup who can benefit most from better balance and r... should stimulate the sensory system and therefore...
...new type of vaccine can reduce the incidence of pn...eficiency virus (HIV). // Acute respiratory in...der age 5. Additionally, pneumonia is becoming inc...ith nearly 40,000 children in South Africa. At 6 w...
...e found in red meat and milk makes its way into th... especially in tumors, say researchers.// The ...aces of animal cells but is not found in people, a...c. But researchers at have found it does show...
Other Medicine News:Health News:How a man's mind really works 2Health News:Same molecule found in meat, milk, tumors 2
...horse for the lab, featuring easy-to-use control k...e. , Product features , , Digital display w...(W x D) footprint fits on a crowded bench, or in a...otor provides maintenance-free operation , Spin...
...z, 100/120 V Fast - Powerful g-Force for Fast an... up to 14,000 rpm (18,000 x g) Ideal for pelletin... Fits on crowded bench or in a cold room Comes...ble fixed-angle rotor Quiet operation ≤ 58 ...
...f laboratory floor model centrifuge meets UL and C... is suitable for use in Class 1, Group D hazardous... gasoline, petroleum, naphtha, benzol, lacquer, so... specifications is so strict that the EXD design a...
Avanti J-30I
Medicine Products: